Replies to post #135529 on Biotech Values

[DewDiligence]

Any idea on capacity, could enough immunoglobulin be produced? I guess plasma "donations" would become more lucrative.

BAX and its competitors in the plasma-protein arena would surely have to open more collection centers to meet the demand.